about
Endoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formersIncreased risk of acute coronary syndrome among patients with urinary stone disease: a nationwide population-based cohort study.Glyoxylate, a new marker metabolite of type 2 diabetes.Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in FranceMetabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention.Association between metabolic syndrome and pelvic organ prolapse severity.Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, CanadaBenign prostatic hyperplasia complicated with T1DM can be alleviated by treadmill exercise-evidences revealed by the rat modelThe association between metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study in China.Patients with Urinary Incontinence Appear More Likely to Develop Upper Urinary Tract Stones: A Nationwide, Population-Based Study with 8-Year Follow-Up.Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer riskMetabolic syndrome and prostate abnormalities in male subjects of infertile couples.Quality of Life and Sexual Health in the Aging of PCa Survivors.Sperm parameters: paradigmatic index of good health and longevity.The Effect of Different Metabolic Syndrome: Definitions on the Relationship Between Metabolic Syndrome and LUTS in Men With Benign Prostatic Enlargement.Impact of metabolic disorders on prostate cancer growth: Androgen and insulin resistance perspectives.Metabesity and urological cancers.Non-alcoholic fatty liver disease and the development of nephrolithiasis: A cohort study.Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.Epigallocatechin-3-gallate alleviates bladder overactivity in a rat model with metabolic syndrome and ovarian hormone deficiency through mitochondria apoptosis pathways.Metabolic syndrome and benign prostatic hyperplasia: An update.The influence of metabolic syndrome and its components on the development of nephrolithiasis
P2860
Q27303089-08980A64-27A5-4EE1-9B7B-5B329608BD69Q33882842-26AA0648-6123-403F-B77A-7A8B2E952DC2Q34454800-988B6D83-A138-47DF-9BA9-C8D4A440F99BQ35098158-4D768F61-0B01-4B4E-AF81-73097A3E3DA8Q35182377-AF9A5E28-3576-41CF-8FFF-5595F09158AEQ35212239-98380C7B-CCAA-4190-812E-DFD6D847F588Q35781093-6A560477-CD0D-4111-94C3-38BF9959C6DAQ35843929-BB3BBB1E-E39B-4366-A5FB-A0CA15917B56Q35923260-9DA64BF8-F1B5-413D-A553-79AB65D24F4FQ36106625-3862FB2B-177C-41B3-AFA3-3D84D04580ACQ36857502-734C7CD5-AAB5-4047-9742-C2D9CE231DB5Q37639222-E57683B1-1F45-4CAE-AF8B-937931212D0DQ37686901-BE130014-E9F1-4E53-86A1-D871A47203B6Q38139822-46EE2D64-5456-4A33-A2F1-83FAF605558EQ47126131-299D9F02-351D-42BB-AF36-968272563CAEQ47129584-3C50D745-E14D-4C26-90CB-5BD5714CD6D9Q47139943-BFA3A9BF-B7C8-4B3A-9132-4E3754E6E703Q47141621-55A4DB43-0D7C-453B-91D8-37129666973EQ50209126-304E9B9D-A4BA-4060-A197-BB8B766428ABQ55231782-B5C8C6CB-AA02-4800-8F53-5CDB6C2DF319Q55345009-BCEFE979-9187-4B88-90C7-BA8A5CA242E7Q58588786-47AC76A5-1087-4ED5-851C-B873258FFF63
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Metabolic syndrome and urologic diseases.
@en
Metabolic syndrome and urologic diseases.
@nl
type
label
Metabolic syndrome and urologic diseases.
@en
Metabolic syndrome and urologic diseases.
@nl
prefLabel
Metabolic syndrome and urologic diseases.
@en
Metabolic syndrome and urologic diseases.
@nl
P2093
P2860
P1433
P1476
Metabolic syndrome and urologic diseases.
@en
P2093
Dean G Assimos
Haluk Akpinar
Ilya Gorbachinsky
P2860
P304
P577
2010-01-01T00:00:00Z